Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12;27(16):5159.
doi: 10.3390/molecules27165159.

Anti-Obesity Evaluation of Averrhoa carambola L. Leaves and Assessment of Its Polyphenols as Potential α-Glucosidase Inhibitors

Affiliations

Anti-Obesity Evaluation of Averrhoa carambola L. Leaves and Assessment of Its Polyphenols as Potential α-Glucosidase Inhibitors

Nehal S Ramadan et al. Molecules. .

Abstract

Averrhoa carambola L. is reported for its anti-obese and anti-diabetic activities. The present study aimed to investigate its aqueous methanol leaf extract (CLL) in vivo anti-obese activity along with the isolation and identification of bioactive compounds and their in vitro α-glucosidase inhibition assessment. CLL improved all obesity complications and exhibited significant activity in an obese rat model. Fourteen compounds, including four flavone glycosides (1-4) and ten dihydrochalcone glycosides (5-12), were isolated and identified using spectroscopic techniques. New compounds identified in planta included (1) apigenin 6-C-(2-deoxy-β-D-galactopyranoside)-7-O-β-D-quinovopyranoside, (8) phloretin 3'-C-(2-O-(E)-cinnamoyl-3-O-β-D-fucopyranosyl-4-O-acetyl)-β-D-fucopyranosyl-6'-O-β-D fucopyranosyl-(1/2)-α-L arabinofuranoside, (11a) phloretin3'-C-(2-O-(E)-p-coumaroyl-3-O-β-D-fucosyl-4-O-acetyl)-β-D-fucosyl-6'-O-(2-O-β-D-fucosyl)-α-L-arabinofuranoside, (11b) phloretin3'-C-(2-O-(Z)-p-coumaroyl-3-O-β-D-fucosyl-4-O-acetyl)-β-D-fucosyl-6'-O-(2-O-β-D-fucosyl)-α-L-arabinofuranoside. Carambolaside M (5), carambolaside Ia (6), carambolaside J (7), carambolaside I (9), carambolaside P (10a), carambolaside O (10b), and carambolaside Q (12), which are reported for the first time from A. carambola L. leaves, whereas luteolin 6-C-α-L-rhamnopyranosyl-(1-2)-β-D-fucopyranoside (2), apigenin 6-C-β-D-galactopyranoside (3), and apigenin 6-C-α-L-rhamnopyranosyl-(1-2)-β-L-fucopyranoside (4) are isolated for the first time from Family. Oxalidaceae. In vitro α-glucosidase inhibitory activity revealed the potential efficacy of flavone glycosides, viz., 1, 2, 3, and 4 as antidiabetic agents. In contrast, dihydrochalcone glycosides (5-11) showed weak activity, except for compound 12, which showed relatively strong activity.

Keywords: Averrhoa carambola L.; Oxalidaceae; antidiabetic; dihydrochalcone; flavone glycosides; obesity; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Body weight and biochemical parameters in the 4th week of treatment of experimental animals with Orly and CLL compared to normal and obese groups. (A) The initial, final body weights (BW) and BW gain (g). (B) The level of plasma total cholesterol (TCh mg/dL), triglycerides (TG mg/dL), high-density lipoprotein cholesterol (HDL-Ch mg/dL), and low-density lipoprotein cholesterol (LDL-Ch mg/dL). (C) The level of leptin (ng/mL), insulin (μg/L), glucose (mg/dL), and α-amylase (U/L). (D) The level of plasma butyrylcholinesterase (BChE (U/L)) and plasma catalase activity (CAT (U/L)). (E) The level of malondialdehyde (MDA (nmol/mL) and TCh/HDL. (F) The level of plasma uric acid (mg/dL) and plasma creatinine (mg/dL). (G) Calculated insulin resistance (IR). (H) The activity of aspartate transaminase (AST (IU/L)), alanine transaminase (ALT (IU/L)), and urea (mg/dL). Each bar graph represents the mean replicate measurement (n = 6) expressed as mean ± S.E. The bar graphs with a similar lower-case letter (such as ‘a’) among experimental groups are not significantly different from each other (p > 0.05). The bar graphs with different lower-case letters (such as a, b, c, d, and e) are statistically different from each other (p < 0.05).
Figure 2
Figure 2
Chemical structures of compounds 112 isolated from CLL extract.
Figure 3
Figure 3
Key HMBC correlations of compound 1, 8, and 11a.
Figure 4
Figure 4
(A) IC50 (µM) of tested compounds against α-glucosidase enzymes in vitro. (B) The potential sites of flavone C-glycosides affecting α-glucosidase inhibitory potential. (C) The potential sites of dihydrochalcone C-glycosides affecting the α-glucosidase inhibitory potential. The up arrows represent increased inhibition, whereas the down arrows represent decreased inhibition activity. Results are expressed as mean ± SE (n = 3).
Figure 5
Figure 5
Collective scheme for extraction, isolation, and biological activities performed on A. carambola leaves.

Similar articles

Cited by

References

    1. Venkatakrishnan K., Chiu H.-F., Wang C.K. Extensive Review of Popular Functional Foods and Nutraceuticals against Obesity and Its Related Complications with a Special Focus on Randomized Clinical Trials. Food Funct. 2019;10:2313–2329. doi: 10.1039/C9FO00293F. - DOI - PubMed
    1. Gesta S., Tseng Y.-H., Kahn C.R. Developmental Origin of Fat: Tracking Obesity to Its Source. Cell. 2007;131:242–256. doi: 10.1016/j.cell.2007.10.004. - DOI - PubMed
    1. Gamboa-Gómez C.I., Rocha-Guzmán N.E., Gallegos-Infante J.A., Moreno-Jiménez M.R., Vázquez-Cabral B.D., González-Laredo R.F. Plants with Potential Use on Obesity and Its Complications. EXCLI J. 2015;14:809–831. doi: 10.17179/excli2015-186. - DOI - PMC - PubMed
    1. Kinlen D., Cody D., O’Shea D. Complications of Obesity. QJM Int. J. Med. 2018;111:437–443. doi: 10.1093/qjmed/hcx152. - DOI - PubMed
    1. Gani R.S., Kudva A.K., Timanagouda K., Raghuveer, Mujawar S.B.H., Joshi S.D., Raghu S.V. Synthesis of Novel 5-(2,5-Bis(2,2,2-Trifluoroethoxy)Phenyl)-1,3,4-Oxadiazole-2-Thiol Derivatives as Potential Glucosidase Inhibitors. Bioorg. Chem. 2021;114:105046. doi: 10.1016/j.bioorg.2021.105046. - DOI - PubMed

LinkOut - more resources

-